Top Analyst Reports for Procter & Gamble, Thermo Fisher & PayPal

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Procter &amp; Gamble (PG), Thermo Fisher (TMO) and PayPal (PYPL). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.” data-reactid=”19″>The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Thermo Fisher (TMO) and PayPal (PYPL). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="You can see&nbsp;all of&nbsp;today’s&nbsp;research reports here &gt;&gt;&gt;” data-reactid=”20″>You can see all of today’s research reports here >>>

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Procter &amp; Gamble’s shares have outperformed the Zacks Soap and Cleaning Materials industry year to date (+30.9% vs. +20.9%). The Zacks analyst believes that Strong organic sales growth, backed by higher shipment volume and favorable price/mix, boosted the company’s top line.” data-reactid=”21″>Procter & Gamble’s shares have outperformed the Zacks Soap and Cleaning Materials industry year to date (+30.9% vs. +20.9%). The Zacks analyst believes that Strong organic sales growth, backed by higher shipment volume and favorable price/mix, boosted the company’s top line.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="The company’s solid first-quarter fiscal 2020 results, wherein both top and bottom lines not only surpassed the Zacks Consensus Estimate but also improved year over year, is driving the stock momentum. Again, ongoing cost-saving and productivity efforts cushioned margins and in turn the bottom line.” data-reactid=”22″>The company’s solid first-quarter fiscal 2020 results, wherein both top and bottom lines not only surpassed the Zacks Consensus Estimate but also improved year over year, is driving the stock momentum. Again, ongoing cost-saving and productivity efforts cushioned margins and in turn the bottom line.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Impressive performance prompted management to provide an upbeat view for fiscal 2020. The company now projects all-in sales growth of 3-5% and core EPS growth of 5-10%. On the flip side, currency fluctuation remains concerning. Nevertheless, adverse impacts of the same are likely to be offset by slight gain from acquisitions and divestitures.” data-reactid=”23″>Impressive performance prompted management to provide an upbeat view for fiscal 2020. The company now projects all-in sales growth of 3-5% and core EPS growth of 5-10%. On the flip side, currency fluctuation remains concerning. Nevertheless, adverse impacts of the same are likely to be offset by slight gain from acquisitions and divestitures.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="(You can&nbsp;read the full research report on Procter &amp; Gamble here &gt;&gt;&gt;)” data-reactid=”24″>(You can read the full research report on Procter & Gamble here >>>)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Shares of Thermo Fisher have gained 7.5% in the past three months against the Zacks Medical Instruments industry’s rise of 7.2%. The Zacks analyst is looking forward to the company’s recent purchases of Brammer Bio in the field of Gene and Cell Therapy and an active pharmaceutical ingredient manufacturing facility from GlaxoSmithKline.” data-reactid=”25″>Shares of Thermo Fisher have gained 7.5% in the past three months against the Zacks Medical Instruments industry’s rise of 7.2%. The Zacks analyst is looking forward to the company’s recent purchases of Brammer Bio in the field of Gene and Cell Therapy and an active pharmaceutical ingredient manufacturing facility from GlaxoSmithKline.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Thermo Fisher ended the third quarter of 2019 with better-than-expected numbers. Barring industrial and applied, the company saw strength in all three end markets too. Further, the company registered solid international performance with strong growth in Europe and Asia-Pacific including China. Also, a series of product launches with progress in precision medicine initiatives aided the company’s performance.” data-reactid=”26″>Thermo Fisher ended the third quarter of 2019 with better-than-expected numbers. Barring industrial and applied, the company saw strength in all three end markets too. Further, the company registered solid international performance with strong growth in Europe and Asia-Pacific including China. Also, a series of product launches with progress in precision medicine initiatives aided the company’s performance.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="On the flip side, Thermo Fisher’s operating segments are getting impacted by unfavorable business mix. Competitive headwinds and escalating costs pose threat.” data-reactid=”27″>On the flip side, Thermo Fisher’s operating segments are getting impacted by unfavorable business mix. Competitive headwinds and escalating costs pose threat.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="(You can&nbsp;read the full research report on Thermo Fisher here &gt;&gt;&gt;)” data-reactid=”28″>(You can read the full research report on Thermo Fisher here >>>)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="PayPal‘s shares have lost 6.8% over the past six months against the Zacks Internet Software industry’s fall of 4.1%. The Zacks analyst believes that PayPal is driven by growth in total payments volume owing to Venmo and One Touch.” data-reactid=”29″>PayPal‘s shares have lost 6.8% over the past six months against the Zacks Internet Software industry’s fall of 4.1%. The Zacks analyst believes that PayPal is driven by growth in total payments volume owing to Venmo and One Touch.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Also, increasing net new active accounts and strengthening customer engagement on the company’s platform are positives. Additionally, growing momentum of the company’s core peer to peer and merchant services remains positive.” data-reactid=”30″>Also, increasing net new active accounts and strengthening customer engagement on the company’s platform are positives. Additionally, growing momentum of the company’s core peer to peer and merchant services remains positive.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="However, declining eBay volume remains a headwind for the company’s total payment volume. Sale of the U.S. consumer credit receivables portfolio to Synchrony are risks to PayPal’s top-line growth. Also, increasing competition from Square remains a major concern.” data-reactid=”31″>However, declining eBay volume remains a headwind for the company’s total payment volume. Sale of the U.S. consumer credit receivables portfolio to Synchrony are risks to PayPal’s top-line growth. Also, increasing competition from Square remains a major concern.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="(You can&nbsp;read the full research report on PayPal here &gt;&gt;&gt;)” data-reactid=”32″>(You can read the full research report on PayPal here >>>)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Other noteworthy reports we are featuring today include NextEra Energy (NEE), Petrobras (PBR) and Enterprise Products (EPD).” data-reactid=”33″>Other noteworthy reports we are featuring today include NextEra Energy (NEE), Petrobras (PBR) and Enterprise Products (EPD).

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Today’s Best Stocks from Zacks” data-reactid=”34″>Today’s Best Stocks from Zacks

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&amp;P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.” data-reactid=”35″>Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&amp;P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.” data-reactid=”36″>This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="See their latest picks free &gt;&gt;” data-reactid=”37″>See their latest picks free >>

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Mark Vickery
Senior Editor” data-reactid=”38″>Mark Vickery
Senior Editor

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly&nbsp;Earnings Trends&nbsp;and&nbsp;Earnings Preview&nbsp;reports. If you want an email notification each time Sheraz publishes a new article, please&nbsp;click here&gt;&gt;&gt;” data-reactid=”39″>Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today’s Must Read

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="P&amp;G’s (PG) Productivity &amp; Cost Savings Plan to Aid Margins” data-reactid=”41″>P&G’s (PG) Productivity & Cost Savings Plan to Aid Margins